Journal of Alzheimer s Disease,
Journal Year:
2023,
Volume and Issue:
93(3), P. 863 - 878
Published: April 25, 2023
As
the
size
of
population
aged
65
and
older
continues
to
grow,
incidence
mortality
rates
Alzheimer’s
disease
(AD)
are
increasing
annually.
Unfortunately,
current
treatments
only
treat
symptoms
temporarily
do
not
alter
patients’
life
expectancy
or
course
AD.
Mesenchymal
stem
cells
(MSCs)
have
shown
a
certain
therapeutic
potential
in
neurodegenerative
diseases
including
AD
due
their
neuroinflammatory
regulation
neuroprotective
effects.
However,
low
survival
homing
MSCs
after
transplantation
seriously
affect
effectiveness.
Therefore,
appropriate
vitro
preconditioning
is
necessary
increase
improve
effectiveness
treating
Here
we
summarize
mechanisms
chemical
reagents
used
for
pretreatment
MSCs.
Food Reviews International,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 50
Published: Jan. 4, 2025
Cancer
is
the
world's
second
most
common
cause
of
death,
with
colon
cancer
(CC)
ranking
third
in
prevalence
and
cancer-related
fatalities.
CC
originates
or
rectum
influenced
by
genetic
mutations,
lifestyle,
diet.
Although
chemotherapy,
especially
5-fluorouracil
(5-FU),
fundamental
to
treatment
has
improved
patient
survival,
its
benefits
are
often
limited
significant
side
effects
emerging
drug
resistance.
Recently,
plant-based
foods
have
drawn
interest
research
for
their
natural
bioactive
compounds
relatively
low
toxicity.
Certain
plant
not
only
exhibit
anti-cancer
activity
but
may
also
boost
effectiveness
5-FU
while
reducing
adverse
effects.
Despite
evidence
suggesting
a
synergistic
effect
between
5-FU,
this
area
remains
fragmented.
This
review
consolidates
current
on
including
fruits,
vegetables,
legumes,
tea
bioactives
treatment.
Besides,
it
explores
mechanisms
through
which
these
enhance
efficacy
reduce
effects,
evaluates
clinical
application
prospects,
identifies
challenges
future
directions.
comprehensive
analysis
aims
provide
scientific
foundation
integrated
CC,
highlighting
potential
enhancing
chemotherapy
associated
toxicities.
Molecules,
Journal Year:
2022,
Volume and Issue:
27(15), P. 4818 - 4818
Published: July 27, 2022
Cancer
is
the
second
leading
cause
of
death
after
cardiovascular
diseases.
Conventional
anticancer
therapies
are
associated
with
lack
selectivity
and
serious
side
effects.
hallmarks
biological
capabilities
acquired
by
cancer
cells
during
neoplastic
transformation.
Targeting
multiple
a
promising
strategy
to
treat
cancer.
The
diversity
in
chemical
structure
relatively
low
toxicity
make
plant-derived
natural
products
source
for
development
new
more
effective
that
have
capacity
target
In
this
review,
we
discussed
activities
ten
extracted
from
plants.
majority
these
inhibit
targeting
hallmarks,
many
chemicals
reached
clinical
applications.
Studies
review
provide
solid
ground
researchers
physicians
design
combination
using
products.
Cancer Cell International,
Journal Year:
2022,
Volume and Issue:
22(1)
Published: April 2, 2022
5-fluorouracil
(5-FU),
an
effective
chemotherapy
drug,
is
commonly
applied
for
colorectal
cancer
treatment.
Nevertheless,
its
toxicity
to
normal
tissues
and
the
development
of
tumor
resistance
are
main
obstacles
successful
hence,
clinical
application
limited.
The
use
resveratrol
can
increase
5-FU-induced
cytotoxicity
mitigate
unwanted
adverse
effects.
This
study
aimed
review
potential
therapeutic
effects
in
combination
with
5-FU
against
cancer.
Cancer and Metastasis Reviews,
Journal Year:
2023,
Volume and Issue:
43(1), P. 55 - 85
Published: July 29, 2023
Abstract
Despite
tremendous
medical
treatment
successes,
colorectal
cancer
(CRC)
remains
a
leading
cause
of
deaths
worldwide.
Chemotherapy
as
monotherapy
can
lead
to
significant
side
effects
and
chemoresistance
that
be
linked
several
resistance-activating
biological
processes,
including
an
increase
in
inflammation,
cellular
plasticity,
multidrug
resistance
(MDR),
inhibition
the
sentinel
gene
p53,
apoptosis.
As
consequence,
tumor
cells
escape
effectiveness
chemotherapeutic
agents.
This
underscores
need
for
cross-target
therapeutic
approaches
are
not
only
pharmacologically
safe
but
also
modulate
multiple
potent
signaling
pathways
sensitize
overcome
standard
drugs.
In
recent
years,
scientists
have
been
searching
natural
compounds
used
chemosensitizers
addition
conventional
medications
synergistic
CRC.
Resveratrol,
polyphenolic
phytoalexin
found
various
fruits
vegetables
such
peanuts,
berries,
red
grapes,
is
one
most
effective
chemopreventive
Abundant
vitro
vivo
studies
shown
resveratrol,
interaction
with
drugs,
chemosensitizer
CRC
agents
thus
prevents
drug
by
modulating
pathways,
transcription
factors,
epithelial-to-mesenchymal
transition-plasticity,
proliferation,
metastasis,
angiogenesis,
cell
cycle,
The
ability
resveratrol
modify
subcellular
may
suppress
plasticity
reversal
critical
parameters
understanding
its
anti-cancer
effects.
this
review,
we
focus
on
chemosensitizing
properties
and,
thus,
potential
importance
additive
ongoing
treatments.
Graphical
abstract
Molecules,
Journal Year:
2023,
Volume and Issue:
28(9), P. 3746 - 3746
Published: April 26, 2023
This
review
article
describes
studies
published
over
the
past
five
years
on
combination
of
polyphenols,
which
are
most
studied
in
field
anticancer
effects
(curcumin,
quercetin,
resveratrol,
epigallocatechin
gallate,
and
apigenin)
chemotherapeutics
such
as
cisplatin,
5-fluorouracil,
oxaliplatin,
paclitaxel,
etc.
According
to
WHO
data,
research
has
been
limited
cancers
with
highest
morbidity
rate
(lung,
colorectal,
liver,
gastric,
breast
cancer).
A
systematic
articles
(from
January
2018
2023)
was
carried
out
help
all
Web
Science
databases
available
base
clinical
studies.
Based
preclinical
presented
this
review,
polyphenols
can
enhance
drug
efficacy
reduce
chemoresistance
through
different
molecular
mechanisms.
Considering
large
number
studies,
curcumin
could
be
a
molecule
future
chemotherapy
cocktails.
One
main
problems
is
related
bioavailability
polyphenols.
The
design
new
co-delivery
system
for
drugs
essential
research.
Some
work
synergy
chemotherapeutic
drugs,
but
some
act
antagonistically,
so
caution
always
required.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(11), P. 4322 - 4322
Published: May 24, 2023
Colorectal
cancer
(CRC)
is
the
third
most
common
worldwide
and
its
incidence
expected
to
increase
by
almost
80%
2030.
CRC
apparition
related
poor
diet,
mainly
due
low
consumption
of
phytochemicals
present
in
fruits
vegetables.
Hence,
this
paper
reviews
promising
literature,
presenting
scientific
evidence
regarding
potential
chemopreventive
effects.
Moreover,
reveals
structure
action
mechanisms
that
these
are
involved
in.
The
review
vegetables
rich
such
as
carrots
green
leafy
vegetables,
well
some
pineapple,
citrus
fruits,
papaya,
mango,
Cape
gooseberry,
have
antioxidant,
anti-inflammatory,
properties
can
promote
a
healthy
colonic
environment.
Fruits
daily
diet
antitumor
regulating
cell
signaling
and/or
proliferation
pathways.
plant
products
recommended
reduce
risk
CRC.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(16)
Published: Feb. 28, 2024
Abstract
Traditional
Chinese
Medicine
(TCM)
is
widely
used
in
clinical
practice
to
treat
diseases
related
central
nervous
system
(CNS)
damage.
However,
the
blood‐brain
barrier
(BBB)
constitutes
a
significant
impediment
effective
delivery
of
TCM,
thus
substantially
diminishing
its
efficacy.
Advances
nanotechnology
and
applications
TCM
(also
known
as
nano‐TCM)
can
deliver
active
ingredients
or
components
across
BBB
targeted
brain
region.
This
review
provides
an
overview
physiological
pathological
mechanisms
systematically
classifies
common
CNS
types
nanocarriers
that
effectively
brain.
Additionally,
drug
strategies
for
nano‐TCMs
utilize
vivo
properties
vitro
devices
bypass
cross
are
discussed.
further
focuses
on
application
treatment
various
diseases.
Finally,
this
article
anticipates
design
strategy
with
higher
efficiency
probes
their
potential
treating
wider
range
Particle & Particle Systems Characterization,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 28, 2024
Abstract
Despite
progress
in
cancer
treatments,
it
remains
a
leading
cause
of
death
worldwide.
Current
chemotherapy
is
often
hampered
by
side
effects,
tissue
damage,
and
drug
resistance.
To
overcome
these
limitations,
research
exploring
new
approaches
to
improve
efficacy
reduce
its
effects.
A
promising
strategy
involves
combining
chemotherapeutic
drugs
with
phytochemicals,
which
are
active
compounds
derived
from
plants.
Nanotechnology
plays
crucial
role
delivering
often‐hydrophobic
drugs,
enhancing
their
bioavailability
solubility.
This
area
represents
significant
convergence
nanotechnology
both
conventional
pharmaceuticals
botanical
compounds.
Global
studies
increasingly
demonstrating
the
potential
combination
therapies
inhibit
cell
growth
laboratory
preclinical
models.
These
suggest
synergistic
or
additive
effects
that
lead
improved
treatment
outcomes.
article
focuses
on
recent
advancements
nano‐drug
delivery
systems,
specifically
those
designed
for
simultaneous
phytochemicals.
It
explores
selection
phytochemicals
based
anticancer
properties,
outlines
design
considerations
nanocarriers,
discusses
how
physicochemical
characteristics
influence
release
kinetics.
Additionally,
review
examines
nanoformulations
integrate
synthetic
natural
components,
highlighting
herbal
oils
medicines
treatment.
International Journal of Medical Sciences,
Journal Year:
2024,
Volume and Issue:
21(5), P. 809 - 816
Published: Jan. 1, 2024
This
comprehensive
review
delves
into
the
pivotal
role
of
mitochondria
in
doxorubicin-induced
cardiotoxicity,
a
significant
complication
limiting
clinical
use
this
potent
anthracycline
chemotherapeutic
agent.Doxorubicin,
while
effective
against
various
malignancies,
is
associated
with
dose-dependent
potentially
leading
to
irreversible
cardiac
damage.The
meticulously
dissects
molecular
mechanisms
underpinning
particularly
focusing
on
mitochondrial
dysfunction,
central
player
adverse
effect.Central
discussion
concept
quality
control
(MQC),
including
dynamics
(fusion/fission
balance)
and
mitophagy.The
presents
evidence
linking
aberrations
these
processes
cardiotoxicity
doxorubicin-treated
patients.It
elucidates
how
doxorubicin
disrupts
dynamics,
an
imbalance
between
fission
fusion,
impairs
mitophagy,
culminating
accumulation
dysfunctional
subsequent
cell
damage.Furthermore,
explores
emerging
therapeutic
strategies
targeting
dysfunction.It
highlights
potential
modulating
enhancing
mitophagy
mitigate
damage.These
include
pharmacological
interventions
inhibitors,
fusion
promoters,
agents
that
modulate
underscores
promising
results
from
preclinical
studies
advocating
for
more
extensive
trials
validate
approaches
human
patients.In
conclusion,
offers
valuable
insights
intricate
relationship
dysfunction
doxorubicin-mediated
cardiotoxicity.It
need
continued
research
targeted
therapies
as
means
improve
safety
profile
doxorubicin,
thereby
overall
treatment
outcomes
cancer
patients.